Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KARUNAKAR AKASAPU

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1366671117
CMS profile
687217
Location
NORTH RICHLAND HILLS, TX

General Payments · PY2018–2024

$9,225.01

  • Reported across 513 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$315.20

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $315.20 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,778.31 130
PY2019 $2,813.34 115
PY2020 $719.93 56
PY2021 $1,548.04 101
PY2022 $1,431.38 69
PY2023 $618.81 26
PY2024 $315.20 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $17.48 10/03/2024 Food and Beverage Undisputed 01/23/2026 1078863927 CMS
AstraZeneca Pharmaceuticals LP $18.67 03/19/2024 Food and Beverage Undisputed 01/23/2026 1104468888 CMS
AstraZeneca Pharmaceuticals LP $14.70 05/28/2024 Food and Beverage Undisputed 01/23/2026 1104608162 CMS
AstraZeneca Pharmaceuticals LP $20.24 08/20/2024 Food and Beverage Undisputed 01/23/2026 1105462877 CMS
Baxter Healthcare $16.82 07/10/2024 Food and Beverage Undisputed 01/23/2026 1118285888 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.18 02/20/2024 Food and Beverage Undisputed 01/23/2026 1117982032 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.91 07/08/2024 Food and Beverage Undisputed 01/23/2026 1117982036 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.79 09/18/2024 Food and Beverage Undisputed 01/23/2026 1117982034 CMS
GENZYME CORPORATION $25.05 06/26/2024 Food and Beverage Undisputed 01/23/2026 1139664892 CMS
GENZYME CORPORATION $21.03 10/30/2024 Food and Beverage Undisputed 01/23/2026 1139664930 CMS
GlaxoSmithKline, LLC. $17.40 09/03/2024 Food and Beverage Undisputed 01/23/2026 1116667696 CMS
Insmed, Inc. $13.50 11/14/2024 Food and Beverage Undisputed 01/23/2026 1089563648 CMS
Insmed, Inc. $17.80 12/12/2024 Food and Beverage Undisputed 01/23/2026 1089556638 CMS
Mylan Specialty L.P. $21.23 04/10/2024 Food and Beverage Undisputed 01/23/2026 1147348263 CMS
Mylan Specialty L.P. $26.13 05/15/2024 Food and Beverage Undisputed 01/23/2026 1147377478 CMS
Mylan Specialty L.P. $22.27 08/08/2024 Food and Beverage Undisputed 01/23/2026 1147300675 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.